Patents by Inventor Kingsley Iyoha

Kingsley Iyoha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRF1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
    Publication number: 20230255942
    Abstract: Provided are methods related to treating congenital adrenal hyperplasia in a subject in need thereof comprising administering to the subject a compound of Formula (I): [INSERT FORMULA] (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 9, 2021
    Publication date: August 17, 2023
    Inventors: Robert H. Farber, Jean L. Chan, Eiry Roberts, Gordon B. Cutler, JR., Arline Nakanishi, Anne Charlier, Gordon Raphael Loewen, Xiaoping Zhang, Nagdeep Giri, Scott Stirn, Brian Sayers, Graeme Taylor, Christina Marie Costa, Stacy Parks, Anthony D. Vickery, Kristie M. Downing, Kingsley Iyoha, Ayanda Ngwenya-Jones, Gurvinder Mehton
  • CRF1 RECEPTOR ANTAGONIST, PHARMACEUTICAL FORMULATIONS AND SOLID FORMS THEREOF FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
    Publication number: 20220023266
    Abstract: Provided are methods related to treating congenital adrenal hyperplasia in a subject in need thereof comprising administering 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-prop-2-ynyl-1,3-thiazol-2-amine (Formula 1), or a pharmaceutically acceptable salt thereof. Further provided are pharmaceutical formulations and solid forms of 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-prop-2-ynyl-1,3-thiazol-2-amine, or a pharmaceutically acceptable salt thereof, and their use in the treatment of congenital adrenal hyperplasia (CAH).
    Type: Application
    Filed: December 6, 2019
    Publication date: January 27, 2022
    Inventors: Robert H. FARBER, Gordon Raphael LOEWEN, Xiaoping ZHANG, Nagdeep GIRI, Jean L. CHAN, Scott STIRN, Brian SAYERS, Graeme TAYLOR, Christina Marie COSTA, Stacy PARKS, Anthony D. VICKERY, Kristie M. DOWNING, Kingsley IYOHA, Ayanda NGWENYA-JONES, Anne CHARLIER, Gurvinder Singh MEHTON
  • Oral composition comprising a cooling agent
    Patent number: 9764034
    Abstract: The present invention relates to a formulation comprising an endothermic cooling agent selected from the group consisting of xylitol, sorbitol, mannitol and erythritol having a heat of enthalpy between ?10 cal/g and ?100 cal/g, and one or more active agents wherein the endothermic agent is present in the formulation at an amount less than 10% w/w.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: September 19, 2017
    Assignee: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
    Inventors: Kingsley Iyoha, Neil Campbell Muir, Robert Rhoades, Alden Rodwell, David Michael Thurgood
  • ORAL COMPOSITION COMPRISING A COOLING AGENT
    Publication number: 20160228552
    Abstract: The present invention relates to a formulation comprising an endothermic cooling agent selected from the group consisting of xylitol, sorbitol, mannitol and erythritol having a heat of enthalpy between ?10 cal/g and ?100 cal/g, and one or more active agents wherein the endothermic agent is present in the formulation at an amount less than 10% w/w.
    Type: Application
    Filed: April 18, 2016
    Publication date: August 11, 2016
    Inventors: Kingsley Iyoha, Neil Campbell Muir, Robert Rhoades, Alden Rodwell, David Michael Thurgood
  • Oral composition comprising a cooling agent
    Patent number: 9314428
    Abstract: The present invention relates to a formulation comprising an endothermic cooling agent selected from the group consisting of xylitol, sorbitol, mannitol and erythritol having a heat of enthalpy between ?10 cal/g and ?100 cal/g, and one or more active agents wherein the endothermic agent is present in the formulation at an amount less than 10% w/w.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: April 19, 2016
    Assignee: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
    Inventors: Kingsley Iyoha, Neil Campbell Muir, Robert Rhoades, Alden Rodwell, David Michael Thurgood
  • Oral Composition Comprising A Cooling Agent
    Publication number: 20100216830
    Abstract: The present invention relates to a formulation comprising an endothermic cooling agent selected from the group consisting of xylitol, sorbitol, mannitol and erythritol having a heat of enthalpy between ?10 cal/g and ?100 cal/g, and one or more active agents wherein the endothermic agent is present in the formulation at an amount less than 10% w/w.
    Type: Application
    Filed: October 17, 2008
    Publication date: August 26, 2010
    Applicant: Reckitt Benckkiser Healthcare (UK) Limted
    Inventors: Kingsley Iyoha, Neil Campbell Muir, Robert Rhoades, Alden Rodwell, David Michael Thurgood